Medications ›tesamorelin

tesamorelin

RxCUI 1044584 ingredient

Contraindicated with · 25

Diagnoses6

Hypopituitarism Craniocerebral Trauma Trauma, Nervous System Pregnancy Reproduction Drug Hypersensitivity

Condition families19

Hypothalamic Neoplasms Supratentorial Neoplasms Pituitary Neoplasms Hypothalamic Diseases Pituitary Diseases Brain Neoplasms Central Nervous System Neoplasms Endocrine Gland Neoplasms Nervous System Neoplasms Wounds and Injuries Endocrine System Diseases Brain Diseases Neoplasms by Site Central Nervous System Diseases Reproductive Physiological Phenomena Neoplasms Nervous System Diseases Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 22

Diagnoses4

HIV-Associated Lipodystrophy Syndrome Lipodystrophy Skin Diseases, Metabolic Sexually Transmitted Diseases, Viral

Condition families18

Lipid Metabolism Disorders HIV Infections Lentivirus Infections Retroviridae Infections Blood-Borne Infections Immunologic Deficiency Syndromes Sexually Transmitted Diseases RNA Virus Infections Communicable Diseases Virus Diseases Genital Diseases Metabolic Diseases Nutritional and Metabolic Diseases Skin Diseases Skin and Connective Tissue Diseases Urogenital Diseases Infections Immune System Diseases

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.